PAA21 DEVELOPMENT OF A COST-UTILITY MODEL FOR COMPARING...

Value in Health 2007 Vol. 10; Iss. 6

PAA21 DEVELOPMENT OF A COST-UTILITY MODEL FOR COMPARING GINA STEP 3 ASTHMA MEDICATIONS BASED ON UTILITY AND SAFETY DATA DERIVED FROM A LARGE HEAD-TO-HEAD TRIAL OF MONTELUKAST AND SALMETEROL

T Soroncz-Szabo, SD Taylor, L Nagy, V Sazonov Kocevar
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65413-7
File:
PDF, 74 KB
english, 2007
Conversion to is in progress
Conversion to is failed